"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II st...

by Marchetti Paolo, Mancini Maria, De Galitiis Federica, Tudini Marianna, Baldi Paola, Cannita Katia, Santomaggio Alessandra, Bruera Gemma, Antonucci Adelmo, Ficorella Corrado, Ricevuto Enrico
Published 2010-10-01

Prognostic value of <it>KRAS </it>genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to ext...

by Bruera Gemma, Cannita Katia, Di Giacomo Daniela, Lamy Aude, Troncone Giancarlo, Dal Mas Antonella, Coletti Gino, Frébourg Thierry, Sabourin Jean, Tosi Mario, Ficorella Corrado, Ricevuto Enrico
Published 2012-11-01